search
Back to results

The Clinical Referral to Activity Study

Primary Purpose

Physical Inactivity, Cardiovascular Risk Factor, Obesity

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
ActiveGOALSv2
PAT
Sponsored by
University of Pittsburgh
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Physical Inactivity focused on measuring Physical activity, Online lifestyle Intervention, Cardiovascular disease, Disease prevention

Eligibility Criteria

40 Years - 70 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Age 40-70 years of age
  • Low physical activity (PA) levels (<150 minutes/week)
  • At least one of the following common cardiometabolic risk factors:

    • high blood pressure:> 129 mm hg SP or >89 mm hg DP or medication
    • high fasting glucose:>100 mg/dl or high HbA1c: ≥42 mmols/mol or medication
    • overweight/ obesity: BMI ≥25 kg/m2).
  • Have access to the internet
  • Able to read English at a 6th grade level
  • Have primary care provider (PCP) permission to increase physical activity without supervision.

Exclusion Criteria:

  • Have participated in a physical activity intervention program with behavior tracking and goal setting in the past year.
  • Told by a physician that they have diabetes (other than previous gestational diabetes) or have received a diagnosis of cardiovascular disease, regardless of when.
  • Pregnant or planning a pregnancy in <12 months
  • Non-ambulatory or planning a procedure that will lead to not being ambulatory in <12 months.
  • Women who become pregnant during the study will be required to get an updated referral form from their primary care provider (PCP) stating that they are able to increase their physical activity without supervision .

Sites / Locations

  • University of PittsburghRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

PAT (Physical activity monitor)

ActiveGOALSv2

Arm Description

Participants will receive a physical activity tracker and encouragement to increase physical activity.

Participants will receive the ActiveGOALS online program with an integrated activity tracker.

Outcomes

Primary Outcome Measures

Change from baseline in meeting the aerobic activity goal at 12 months
Change between 0 and 12 months for y/n meeting the 150 minute/week moderate-vigorous activity goal based on minutes of activity from accelerometer
Change from baseline in Step counts at 12 months
Objectively measured change in step counts between 0 and 12 months using ActiGraph accelerometer

Secondary Outcome Measures

Sedentary behavior minutes over all timepoints for 12 months
Objectively measured sedentary behavior over all timepoints for 12 months using ActiGraph accelerometer
Moderate-vigorous activity minutes over all timepoints for 12 months
Objectively measured moderate-vigorous activity over all timepoints for 12 months using ActiGraph accelerometer
Light activity minutes over all timepoints for 12 months
Objectively measured Light activity over all timepoints for 12 months using ActiGraph accelerometer
Step counts over all timepoints for 12 months
Objectively measured Step counts over all timepoints for 12 months using ActiGraph accelerometer
Patient experience
patient experience survey designed for this study with the help of patient partners to gather feedback from participants. Feedback will be used in the development of future interventions
Blood Pressure over all timepoints for 12 months
Taken by trained clinic staff using a validated automated blood pressure cuff after participant is seated in an upright position for 5 minutes. Two measure will be taken and the average of the two measures will be used. If the measures are not within 5 mmHG, a third measure will be taken.
Body Weight over all timepoints for 12 months
will be measured in clinic by trained staff using a validated scale. Participants will be asked to take shoes off and wear light clothes. Average of two measures will be used; if weight is more than .5 pounds different, a third will be taken.
Waist Circumference over all timepoints for 12 months
will be measured above the iliac crest in clinic by trained staff. Two measures will be taken and averaged; if measures are more than 1 cm different a third measure will be taken.
Fasting Blood Glucose over all timepoints for 12 months
A fasting blood draw will be taken after 12-16 hours fast.
HbA1c over all timepoints for 12 months
A fasting blood draw will be taken after 12-16 hours fast.
LDL Cholesterol over all timepoints for 12 months
A fasting blood draw will be taken after 12-16 hours fast.
HDL Cholesterol over all timepoints for 12 months
A fasting blood draw will be taken after 12-16 hours fast.
Perceived Health Score over all timepoints for 12 months
EuroQAL Visual Analogue Scale (EQ-VAS)-Self-reported perception of health on a 0 (lowest possible) to 100 (highest possible) scale.
Insulin over all timepoints for 12 months
A fasting blood draw will be taken after 12-16 hours fast.
Triglycerides over all timepoints for 12 months
A fasting blood draw will be taken after 12-16 hours fast.

Full Information

First Posted
January 10, 2021
Last Updated
June 7, 2023
Sponsor
University of Pittsburgh
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
search

1. Study Identification

Unique Protocol Identification Number
NCT04743856
Brief Title
The Clinical Referral to Activity Study
Official Title
Advancement of Clinical Referral to Physical Activity for Cardiometabolic Disease Prevention
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 29, 2022 (Actual)
Primary Completion Date
May 31, 2024 (Anticipated)
Study Completion Date
May 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pittsburgh
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The main aim of this effort is to test a physical activity intervention, for adult clinical care patients at risk of developing cardiovascular disease. The intervention includes social-cognitive theory-based sessions, remote coaching, a body worn physical activity tracker (PAT), and is delivered online over one year. The investigators hypothesis that this intervention will be more successful at increasing physical activity (defined as objectively measured step counts and % of individuals meeting the moderate-vigorous physical activity goal) as an active control group who receives a body worn PAT and information on the CDC activity recommendations. The proposed intervention will be aligned with efforts by the US Centers for Disease Control to increase population physical activity levels and the American College of Sports Medicine (ACSM) to increase physical activity prescription in primary care.
Detailed Description
The main aim of this effort is to test a physical activity intervention, for adult clinical care patients at risk of developing cardiovascular disease. The intervention includes 13 weekly and 6 monthly social-cognitive theory-based sessions, remote coaching, a body worn physical activity tracker (PAT), and is delivered online over one year. A total of n=54 Clinical care patients aged 40-70 years of age with low physical activity (PA) levels (<150 minutes/week) at risk for cardiovascular disease will be recruited. Study outcomes will be measured at baseline, 6 months after intervention start and 12 months after intervention start. For the primary outcomes, the investigators hypothesize that participants randomized to ActiveGOALSv2 + PAT will have significantly larger (a) increases in step counts/day and % meeting moderate-vigorous physical activity goal of 150 minutes/week (to 12 months) compared to the active PAT control group. Descriptive analyses and graphic displays will be used to identify outliers, missing data, and pattern of attrition. To ensure rigor, the primary analytic strategy will be a linear or generalized mixed-effect models approach in which treatment group, time, and time by group interaction are treated as fixed effects, and subject is treated as a random effect to account for individual subject variability (two sided hypothesis test; .05 level). Mixed models are applicable to longitudinal datasets that contain missing observations, (assuming data is missing at random). Regression modeling will be conducted to adjust for important covariates. The investigators will perform similar analyses to examine changes in secondary outcomes. Descriptive statistics on patient experience, beliefs/attitudes related to maintenance of physical activity changes, and program cost will also be reported. Power and sample size: For a 2 sided test with alpha level set at .05, and assuming 20% attrition at 12 months, the investigators plan to recruit 54 participants to identify clinically relevant mean difference between randomized groups at 12-months of 2000 steps/day (with a power of .80), and 35% meeting MVPA goal (with a power of .80), given reference mean (sd) values were calculated from baseline waist worn accelerometer data from the current K12 of: 5250 (2200) steps/ day and the investigators assume 5% meeting goal at baseline in the control group. Descriptive statistics will be used to describe the total eligible population, those referred, and those referred who participated in the study; in order to determine program reach. Exploratory Analysis of Important Pre-Existing Factors: Factor analysis will be used to identify importance of factors related to physical activity levels/ activity goal achievement over the 12 month follow-up (Mplus) from participant EHR data collected prior to intervention start. Factor structures of how individual factors contribute to activity outcomes will be explored at each time point. The best factor structure will be determined with Eigenvalues and fit indices (RMSEA, CFI, and TLI). Factor structures at the 2 time points will be compared at three levels to establish measurement invariance: 1) Configural equivalence, number of factors/ pattern of factor-indicator relationships are identical over time; 2) Metric equivalence, factor loadings are equal over time; and 3) Scalar equivalence, means and values are equivalent over time. Finally, the investigators will use descriptive statistics to report presence/absence of data on physical activity levels, cardiometabolic, and patient-centered outcomes in the EHR. The investigators will apply the same regression approaches utilized in Aim 1a to determine differences between randomized groups for EHR reported outcomes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Physical Inactivity, Cardiovascular Risk Factor, Obesity, Blood Pressure, PreDiabetes
Keywords
Physical activity, Online lifestyle Intervention, Cardiovascular disease, Disease prevention

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants will be randomized 1:1 to one of two intervention conditions.
Masking
Care ProviderOutcomes Assessor
Masking Description
Referring doctors and outcome assessors will be blinded to participant assignment while the study is active. After data collection ends, referring physicians will be informed as to each of their patients assignment. Outcome assessors will remain blinded to participant assignment. Investigators will be blinded to assignment as much as possible. However, certain events ( such as an adverse event report) may cause the study PI to become unblinded.
Allocation
Randomized
Enrollment
54 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
PAT (Physical activity monitor)
Arm Type
Active Comparator
Arm Description
Participants will receive a physical activity tracker and encouragement to increase physical activity.
Arm Title
ActiveGOALSv2
Arm Type
Experimental
Arm Description
Participants will receive the ActiveGOALS online program with an integrated activity tracker.
Intervention Type
Behavioral
Intervention Name(s)
ActiveGOALSv2
Intervention Description
13 weekly self-guided sessions on problem solving and goal setting related to increasing physical activity, and weekly remote coaching support. Once a month support materials sent monthly from months 4-12 of intervention.
Intervention Type
Behavioral
Intervention Name(s)
PAT
Intervention Description
Participants will receive a physical activity tracker and encouragement to increase activity.
Primary Outcome Measure Information:
Title
Change from baseline in meeting the aerobic activity goal at 12 months
Description
Change between 0 and 12 months for y/n meeting the 150 minute/week moderate-vigorous activity goal based on minutes of activity from accelerometer
Time Frame
12 months versus baseline
Title
Change from baseline in Step counts at 12 months
Description
Objectively measured change in step counts between 0 and 12 months using ActiGraph accelerometer
Time Frame
12 months versus baseline
Secondary Outcome Measure Information:
Title
Sedentary behavior minutes over all timepoints for 12 months
Description
Objectively measured sedentary behavior over all timepoints for 12 months using ActiGraph accelerometer
Time Frame
1 week recording; measured at baseline, 6 and 12 months
Title
Moderate-vigorous activity minutes over all timepoints for 12 months
Description
Objectively measured moderate-vigorous activity over all timepoints for 12 months using ActiGraph accelerometer
Time Frame
1 week recording; measured at baseline, 6 and 12 months
Title
Light activity minutes over all timepoints for 12 months
Description
Objectively measured Light activity over all timepoints for 12 months using ActiGraph accelerometer
Time Frame
1 week recording; measured at baseline, 6 and 12 months
Title
Step counts over all timepoints for 12 months
Description
Objectively measured Step counts over all timepoints for 12 months using ActiGraph accelerometer
Time Frame
1 week recording; measured at baseline, 6 and 12 months
Title
Patient experience
Description
patient experience survey designed for this study with the help of patient partners to gather feedback from participants. Feedback will be used in the development of future interventions
Time Frame
measured at 6 and 12 months
Title
Blood Pressure over all timepoints for 12 months
Description
Taken by trained clinic staff using a validated automated blood pressure cuff after participant is seated in an upright position for 5 minutes. Two measure will be taken and the average of the two measures will be used. If the measures are not within 5 mmHG, a third measure will be taken.
Time Frame
measured at baseline, 6 and 12 months
Title
Body Weight over all timepoints for 12 months
Description
will be measured in clinic by trained staff using a validated scale. Participants will be asked to take shoes off and wear light clothes. Average of two measures will be used; if weight is more than .5 pounds different, a third will be taken.
Time Frame
measured at baseline, 6 and 12 months
Title
Waist Circumference over all timepoints for 12 months
Description
will be measured above the iliac crest in clinic by trained staff. Two measures will be taken and averaged; if measures are more than 1 cm different a third measure will be taken.
Time Frame
measured at baseline, 6 and 12 months
Title
Fasting Blood Glucose over all timepoints for 12 months
Description
A fasting blood draw will be taken after 12-16 hours fast.
Time Frame
measured at baseline, 6 and 12 months
Title
HbA1c over all timepoints for 12 months
Description
A fasting blood draw will be taken after 12-16 hours fast.
Time Frame
measured at baseline, 6 and 12 months
Title
LDL Cholesterol over all timepoints for 12 months
Description
A fasting blood draw will be taken after 12-16 hours fast.
Time Frame
measured at baseline, 6 and 12 months
Title
HDL Cholesterol over all timepoints for 12 months
Description
A fasting blood draw will be taken after 12-16 hours fast.
Time Frame
measured at baseline, 6 and 12 months
Title
Perceived Health Score over all timepoints for 12 months
Description
EuroQAL Visual Analogue Scale (EQ-VAS)-Self-reported perception of health on a 0 (lowest possible) to 100 (highest possible) scale.
Time Frame
measured at baseline, 6 and 12 months
Title
Insulin over all timepoints for 12 months
Description
A fasting blood draw will be taken after 12-16 hours fast.
Time Frame
measured at baseline, 6 and 12 months
Title
Triglycerides over all timepoints for 12 months
Description
A fasting blood draw will be taken after 12-16 hours fast.
Time Frame
measured at baseline, 6 and 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age 40-70 years of age Low physical activity (PA) levels (<150 minutes/week) At least one of the following common cardiometabolic risk factors: high blood pressure:> 129 mm hg SP or >89 mm hg DP or medication high fasting glucose:>100 mg/dl or high HbA1c: ≥42 mmols/mol or medication overweight/ obesity: BMI ≥25 kg/m2). Have access to the internet Able to read English at a 6th grade level Have primary care provider (PCP) permission to increase physical activity without supervision. Exclusion Criteria: Have participated in a physical activity intervention program with behavior tracking and goal setting in the past year. Told by a physician that they have diabetes (other than previous gestational diabetes) or have received a diagnosis of cardiovascular disease, regardless of when. Pregnant or planning a pregnancy in <12 months Non-ambulatory or planning a procedure that will lead to not being ambulatory in <12 months. Women who become pregnant during the study will be required to get an updated referral form from their primary care provider (PCP) stating that they are able to increase their physical activity without supervision .
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Bonny Rockette-Wagner, PhD
Phone
(412) 624-0118
Email
bjr26@pitt.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bonny Rockette-Wagner, PhD
Organizational Affiliation
University of Pittsburgh
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pittsburgh
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15261
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bonny Rockette-Wagner, PhD
Phone
412-624-0188
Email
bjr26@pitt.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

The Clinical Referral to Activity Study

We'll reach out to this number within 24 hrs